Company to Webcast Presentation Live at 8:00 a.m. ET on Tuesday, November 13th SWINDON, United Kingdom, Nov. 08, 2018 (GLOBE […]
Documented potential for drug candidate with characteristics like WP1122 to reverse immune suppression HOUSTON, Nov. 08, 2018 (GLOBE NEWSWIRE) — […]
Ms. Szela brings expertise in global brand development to Kura as company enters first registration-directed trial SAN DIEGO, Nov. 08, […]
AZEDRA® (iobenguane I 131) Approved by U.S. Food and Drug Administration (FDA) AZEDRA U.S. Launch Progressing and AZEDRA Added to the […]
SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) announced today the schedule of upcoming oral […]
CINCINNATI, Nov. 08, 2018 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter […]
OV101 in Angelman syndrome: Plan to meet with U.S. FDA in the fourth quarter of 2018 to review Phase 2 […]
Commercial team preparing for potential gene therapy launches BOSTON and LONDON, Nov. 08, 2018 (GLOBE NEWSWIRE) — Orchard Therapeutics, a […]
Company to Present Latest Findings at 2018 Society for Immunotherapy of Cancer’s (SITC) Annual Meeting NEW YORK, Nov. 08, 2018 […]
PARSIPPANY, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) — Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that members of its management […]
